Cargando…
Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis
Cell-based therapy is a promising strategy for treating chronic kidney disease (CKD) and is currently the focus of preclinical studies. We performed a systematic review and meta-analysis to evaluate the efficacy of cell-based therapy in preclinical (animal) studies of CKD, and determined factors aff...
Autores principales: | Papazova, Diana A., Oosterhuis, Nynke R., Gremmels, Hendrik, van Koppen, Arianne, Joles, Jaap A., Verhaar, Marianne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348565/ https://www.ncbi.nlm.nih.gov/pubmed/25633980 http://dx.doi.org/10.1242/dmm.017699 |
Ejemplares similares
-
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
por: van Koppen, Arianne, et al.
Publicado: (2015) -
T-cells contribute to hypertension but not to renal injury in mice with subtotal nephrectomy
por: Oosterhuis, Nynke R., et al.
Publicado: (2017) -
Dissecting recipient from donor contribution in experimental kidney transplantation: focus on endothelial proliferation and inflammation
por: Papazova, Diana A., et al.
Publicado: (2018) -
Maintenance of Hypertensive Hemodynamics Does Not Depend on ROS in Established Experimental Chronic Kidney Disease
por: Papazova, Diana A., et al.
Publicado: (2014) -
Human Embryonic Mesenchymal Stem Cell-Derived Conditioned Medium Rescues Kidney Function in Rats with Established Chronic Kidney Disease
por: van Koppen, Arianne, et al.
Publicado: (2012)